Venous thromboembolism prevention in cancer care: implementation strategies to address underuse

Preventing venous thromboembolism for ambulatory patients with cancer: Developing the form and content of implementation strategies

“…This strategy focuses on developing supporting material to make it easier for patients to learn about VTE, risk of VTE, and anticoagulation. It addresses a previously identified barrier of a culture lacking emphasis on VTE prevention relative to cancer care and leverages the finding that patients value VTE prevention [ 16 ]. Clinicians and patients recommended the form to be a concise one-page resource providing content in lay-person language.…”

“…Subsequently, we used the Implementation Research Logic Model (IRLM) – which combines implementation frameworks and can be used as a planning tool– with additional input from oncology clinicians and patients, to identify overarching implementation strategies designed to overcome identified barriers and leverage facilitators ( Fig. 1 ) [ 16 ]. For this study, we focus on four of our previously identified implementation strategies that target clinical (e.g., lower VTE rates), system (e.g., integration of VTE risk-assessment into clinical workflow), and/or implementation outcomes (e.g., adoption, acceptability) [ 16 , 17 ], and for which stakeholders’ input into the form and content was deemed critical ( Fig.…”

“…1 ) [ 16 ]. For this study, we focus on four of our previously identified implementation strategies that target clinical (e.g., lower VTE rates), system (e.g., integration of VTE risk-assessment into clinical workflow), and/or implementation outcomes (e.g., adoption, acceptability) [ 16 , 17 ], and for which stakeholders’ input into the form and content was deemed critical ( Fig. 1 , Panel C).…”